美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

OPUS GENETICS INC

5.75

+0.04000.70%

成交量：43.71万

成交额：249.19万

市值：4.09亿

市盈率：-7.21

高：5.79

开：5.67

低：5.58

收：5.71

52周最高：5.79

52周最低：0.7101

股本：7,114.90万

流通股本：3,490.58万

量比：0.64

换手率：1.25%

股息：- -

股息率：- -

每股收益(TTM):-0.7970

每股收益(LYR):-0.8000

净资产收益率：-242.41%

总资产收益率：-55.39%

市净率：26.66

市盈率(LYR):-7.19

数据加载中...

总览公司新闻资讯公告

奥伯兰资本承诺以每股4.48美元价格向Opus Genetics Inc注资500万美元

Opus Genetics Inc：奥伯兰资本可选择将最多10%票据转换为公司股票，每股作价6.72美元

Opus Genetics Inc获得最高1.55亿美元非稀释性融资首期注资3500万美元

Opus Genetics Inc向SEC提交文件注册740万股普通股供股东转售

Opus Genetics在黄斑学会年会公布Opgx-Best1基因疗法1/2期研究初步临床数据

Opus Genetics宣布FDA受理0.75%酚妥拉明滴眼液补充新药申请用于治疗老花眼

BUZZ--美国股票走势-Opus Genetics、MetaVia、Enbridge

BUZZ-Opus Genetics为视力项目融资2,500万美元后股价走高

Opus Genetics Inc融资由Adage资本管理领投，Trails Edge资本合伙人与Marshall Wace跟投

Opus Genetics Inc预计2025年末模拟现金余额7000万美元，将支撑运营至2028年上半年

Opus Genetics, Inc.盘中异动下午盘股价大涨5.03%报3.55美元

Opus Genetics, Inc.盘中异动急速上涨5.21%

Opus Genetics, Inc.盘中异动股价大跌5.00%

Opus Genetics, Inc.盘中异动临近收盘股价大涨5.18%

Opus Genetics获得独立数据监测委员会对Best病相1/2期临床试验的积极建议

BUZZ--美国股票走势-Coinbase、百思买、Abercrombie & Fitch

BUZZ--美国股票走势-Coinbase、百思买、Abercrombie & Fitch

BUZZ-派博桑德勒给予 Opus Genetics "增持 "评级

Opus Genetics开展Opgx-Best1期1/2基因治疗临床试验，首位参与者已完成给药

Opus Genetics, Inc.盘中异动早盘股价大跌5.08%报1.87美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IRD/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":5.75,"timestamp":1776369600000,"preClose":5.71,"halted":0,"volume":437053,"delay":0,"changeRate":0.007005253940455348,"floatShares":34905800,"shares":71149045,"eps":-0.797002,"marketStatus":"盘前交易","change":0.04,"latestTime":"04-17 05:42:41 EDT","open":5.67,"high":5.79,"low":5.58,"amount":2491866.8576129996,"amplitude":0.036778,"askPrice":6.4,"askSize":100,"bidPrice":4.98,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.797002,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776432600000},"marketStatusCode":1,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":5.75,"postHourTrading":{"tag":"盘后","latestPrice":5.75,"preClose":5.75,"latestTime":"18:43 EDT","volume":5511,"amount":31687.36,"timestamp":1776379412805,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6354864112767673,"impliedVol":0.3806,"impliedVolPercentile":0.0402},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":34905800,"roa":"-55.39%","roe":"-242.41%","lyrEps":-0.8,"volumeRatio":0.6354864112767673,"shares":71149045,"dividePrice":0,"high":5.79,"amplitude":0.036778,"preClose":5.71,"low":5.58,"week52Low":0.7101,"pbRate":"26.66","psRate":"28.82","week52High":5.79,"institutionHeld":0,"latestPrice":5.75,"eps":-0.797002,"divideRate":0,"volume":437053,"delay":0,"ttmEps":-0.797002,"open":5.67,"prevYearClose":2.01,"prevWeekClose":5.36,"prevMonthClose":4.55,"prevQuarterClose":4.55,"fiveDayClose":5.5,"twentyDayClose":4.66,"sixtyDayClose":2.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-10","symbol":"IRD","fiscalQuarterEnding":"2025/12","expectedEps":-0.11,"name":null,"time":"盘前","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-11-12","symbol":"IRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.14,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"IRD","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-31","symbol":"IRD","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"盘前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2143,"buy":0.7857,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7857,"analysts":14,"updateTime":1774929600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2026-04-16","current":-7.214536,"percent":0,"low":-8.192233,"twenty":-2.345893,"median":-1.388969,"eighty":-1.079564,"high":-0.560128,"avg":-2.019605,"sd":1.583704,"marketCap":406261046},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383},{"date":"2025-09-12","current":-1.525447,"twenty":-1.342054,"median":-1.174821,"eighty":-0.822134,"marketCap":88895414},{"date":"2025-09-19","current":-1.611997,"twenty":-1.365273,"median":-1.182227,"eighty":-0.876364,"marketCap":93939125},{"date":"2025-09-26","current":-1.860829,"twenty":-1.384803,"median":-1.184928,"eighty":-0.929339,"marketCap":108439795},{"date":"2025-10-03","current":-1.947379,"twenty":-1.400101,"median":-1.195775,"eighty":-0.939944,"marketCap":113483507},{"date":"2025-10-10","current":-2.152936,"twenty":-1.42988,"median":-1.207384,"eighty":-0.94314,"marketCap":125462322},{"date":"2025-10-17","current":-2.174573,"twenty":-1.477844,"median":-1.207384,"eighty":-0.951343,"marketCap":126723249},{"date":"2025-10-24","current":-2.163754,"twenty":-1.521119,"median":-1.217191,"eighty":-0.957164,"marketCap":126092786},{"date":"2025-10-31","current":-2.131298,"twenty":-1.627334,"median":-1.225421,"eighty":-0.958345,"marketCap":124201394},{"date":"2025-11-07","current":-2.196211,"twenty":-1.661499,"median":-1.23256,"eighty":-0.960734,"marketCap":127984177},{"date":"2025-11-14","current":-2.001473,"twenty":-1.74585,"median":-1.242213,"eighty":-0.964942,"marketCap":116635827},{"date":"2025-11-21","current":-1.951541,"twenty":-1.828372,"median":-1.253822,"eighty":-0.975077,"marketCap":133100921},{"date":"2025-11-28","current":-2.153773,"twenty":-1.878321,"median":-1.253822,"eighty":-0.98727,"marketCap":146893763},{"date":"2025-12-05","current":-2.254889,"twenty":-1.925381,"median":-1.265432,"eighty":-0.988735,"marketCap":153790183},{"date":"2025-12-12","current":-2.467233,"twenty":-1.950709,"median":-1.277041,"eighty":-0.996674,"marketCap":168272667},{"date":"2025-12-19","current":-2.002099,"twenty":-2.002099,"median":-1.288651,"eighty":-1.007767,"marketCap":136549131},{"date":"2025-12-26","current":-2.062768,"twenty":-2.022322,"median":-1.288651,"eighty":-1.0085,"marketCap":140686984},{"date":"2026-01-02","current":-2.032433,"twenty":-2.02248,"median":-1.288651,"eighty":-1.00907,"marketCap":138618058},{"date":"2026-01-09","current":-2.022322,"twenty":-2.035652,"median":-1.288651,"eighty":-1.009619,"marketCap":137928416},{"date":"2026-01-16","current":-2.103215,"twenty":-2.062768,"median":-1.30026,"eighty":-1.016154,"marketCap":143445552},{"date":"2026-01-23","current":-2.527902,"twenty":-2.079519,"median":-1.303662,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-01-30","current":-2.527902,"twenty":-2.105793,"median":-1.31187,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-02-06","current":-2.608795,"twenty":-2.126582,"median":-1.317674,"eighty":-1.019861,"marketCap":177927656},{"date":"2026-02-13","current":-3.427836,"twenty":-2.136977,"median":-1.323479,"eighty":-1.031375,"marketCap":233788665},{"date":"2026-02-20","current":-3.609844,"twenty":-2.149226,"median":-1.323479,"eighty":-1.038117,"marketCap":246202222},{"date":"2026-02-27","current":-3.630068,"twenty":-2.153773,"median":-1.330709,"eighty":-1.044184,"marketCap":247581506},{"date":"2026-03-06","current":-4.823238,"twenty":-2.163754,"median":-1.335088,"eighty":-1.055298,"marketCap":328959272},{"date":"2026-03-13","current":-6.821589,"twenty":-2.163832,"median":-1.335088,"eighty":-1.05838,"marketCap":338289413},{"date":"2026-03-20","current":-6.571003,"twenty":-2.174573,"median":-1.340893,"eighty":-1.062543,"marketCap":325862626},{"date":"2026-03-27","current":-6.48492,"twenty":-2.196211,"median":-1.358307,"eighty":-1.072721,"marketCap":321593683},{"date":"2026-04-02","current":-6.728822,"twenty":-2.279157,"median":-1.369917,"eighty":-1.078827,"marketCap":333689021},{"date":"2026-04-10","current":-7.890943,"twenty":-2.31549,"median":-1.383164,"eighty":-1.078974,"marketCap":391319747},{"date":"2026-04-16","current":-8.192233,"twenty":-2.345893,"median":-1.388969,"eighty":-1.079564,"marketCap":406261046}],"updateTime":1776417506478},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1130712669","title":"奥伯兰资本承诺以每股4.48美元价格向Opus Genetics Inc注资500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130712669","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130712669?lang=zh_cn&edition=fundamental","pubTime":"2026-04-06 19:06","pubTimestamp":1775473583,"startTime":"0","endTime":"0","summary":"奥伯兰资本已正式承诺，将以每股4.48美元的价格对Opus Genetics Inc进行500万美元的股权投资。这项投资将直接用于认购该公司的股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168121332","title":"Opus Genetics Inc：奥伯兰资本可选择将最多10%票据转换为公司股票，每股作价6.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168121332","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168121332?lang=zh_cn&edition=fundamental","pubTime":"2026-04-06 19:06","pubTimestamp":1775473582,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc宣布，其发行的票据中最多10%的部分，可由投资机构奥伯兰资本（Oberland Capital）自主选择转换为公司普通股，转换价格设定为每股6.72美元。此项条款为奥伯兰资本提供了将债权转换为股权的灵活性，潜在增加了其对公司的持股比例。转换价格的设定也反映了市场对公司股权价值的当前评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169713083","title":"Opus Genetics Inc获得最高1.55亿美元非稀释性融资 首期注资3500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169713083","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169713083?lang=zh_cn&edition=fundamental","pubTime":"2026-04-06 19:04","pubTimestamp":1775473459,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc近日宣布成功设立新的票据融资机制，通过该渠道可获得总额高达1.55亿美元的非稀释性资金支持。值得关注的是，该融资方案首期即提供3500万美元的即时资金注入。\n此次融资安排采用票据融资模式，既保障了公司研发资金的持续供给，又有效避免了股权稀释对现有股东权益的影响。非稀释性融资的特性使公司在保持资本结构稳定的同时，能够灵活调配资源推进基因治疗领域的创新研究。\n该融资机制将分阶段释放资金，后续款项的拨付将与公司达成特定研发里程碑挂钩。这种结构化设计既体现了投资方对Opus Genetics技术实力的认可，也为公司未来的科研进展提供了持续动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170710516","title":"Opus Genetics Inc向SEC提交文件 注册740万股普通股供股东转售","url":"https://stock-news.laohu8.com/highlight/detail?id=1170710516","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170710516?lang=zh_cn&edition=fundamental","pubTime":"2026-03-14 05:05","pubTimestamp":1773435900,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc近日向美国证券交易委员会提交文件，正式注册740万股普通股用于二级市场转售。此次注册的股票全部由现有股东提供，旨在为持股人创造流动性机会。根据公开披露信息，这批股票将根据市场情况择机通过公开市场交易进行出售。作为一家专注于眼科基因治疗研发的企业，Opus Genetics Inc此次股权变动备受市场关注。投资者需密切关注后续持股变动公告，以准确把握股东结构变化趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146253007","title":"Opus Genetics在黄斑学会年会公布Opgx-Best1基因疗法1/2期研究初步临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1146253007","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146253007?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 23:13","pubTimestamp":1772205224,"startTime":"0","endTime":"0","summary":"OPUS GENETICS INC于黄斑学会年度会议上首次披露了其Opgx-Best1基因治疗项目的1/2期临床试验初步结果。该研究旨在评估针对遗传性视网膜疾病的新型基因疗法的安全性与有效性。此次数据公布标志着公司在眼科基因治疗领域取得重要进展，为后续临床开发提供了关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199651408","title":"Opus Genetics宣布FDA受理0.75%酚妥拉明滴眼液补充新药申请 用于治疗老花眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1199651408","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199651408?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 19:59","pubTimestamp":1772020779,"startTime":"0","endTime":"0","summary":"Opus Genetics公司近日宣布，美国食品药品监督管理局（FDA）已正式受理其针对0.75%酚妥拉明滴眼液所提交的补充新药申请（sNDA）。该药物旨在用于治疗老花眼，标志着公司在眼科治疗领域取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611689051","title":"BUZZ--美国股票走势-Opus Genetics、MetaVia、Enbridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2611689051","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611689051?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 22:12","pubTimestamp":1770991924,"startTime":"0","endTime":"0","summary":"nL4N3Z90X1 ** Expedia Group Inc EXPE.O:BUZZ - 在预测 2026 年调整后核心利润率增长放缓后下跌。nL4N3Z912F ** Wendy's Co WEN.O:BUZZ - 在年度利润预测低于预期后下跌。nL4N3Z9141 ** Watts Water Technologies Inc WTS.N:BUZZ - 因数据中心需求强劲，Stifel 上调 Watts Water 目标价。nL4N3Z911S ** Instacart Inc CART.O:BUZZ - 因第一季度预测和第四季度业绩乐观而跳涨。nL6N3Z90RQ ** Opus Genetics Inc IRD.O:BUZZ - 在为视力治疗项目融资 2500 万美元后上涨。nL4N3Z90ZC ** Bio-Rad Laboratories Inc BIO.N:BUZZ - 因第四季度利润不及预期而下滑。nL4N3Z9184 ** MetaVia Inc MTVA.O:BUZZ - 因肥胖症药物获得全球专利保护而上涨。nL4N3Z919F ** Enbridge Inc ENB.N:BUZZ - 季度利润超过预期，股价上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL4T3Z91AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAP","AMKR","LU0154245756.USD","DKNG","AU","HWM","HL","LU0788109121.HKD","BK4539","LU2543165471.USD","LU3187612489.SGD","NEM","IMUX","RIVN","TPH","PRU.UK","HK0000914660.USD","LU1169589451.USD","PINS","LU1035773651.USD","ABNB","BK4608","LU0345780950.USD","WTS","LU1015430645.USD","CHRS","EXPE","CART","LU0738911758.USD","ENB","LU0266512127.USD","ROKU","DLTR","RYAN","FDX","MTVA","LU0456854461.SGD","LU2237443978.SGD","TOST","CDE","BK4114","BIO","BK4121","LU1861558580.USD","LU1104425308.USD","LU0345780521.USD","WEN","IRD","LU0345780281.USD","LU2317271919.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611157970","title":"BUZZ-Opus Genetics为视力项目融资2,500万美元后股价走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2611157970","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611157970?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 21:20","pubTimestamp":1770988838,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL4S3Z917L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134293259","title":"Opus Genetics Inc融资由Adage资本管理领投，Trails Edge资本合伙人与Marshall Wace跟投","url":"https://stock-news.laohu8.com/highlight/detail?id=1134293259","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134293259?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 20:33","pubTimestamp":1770985994,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc宣布完成新一轮融资。本轮融资由知名投资机构Adage资本管理担任领投方，同时吸引了Trails Edge资本合伙人与Marshall Wace等投资机构参与跟投。\n此次融资将主要用于推进公司基因治疗管线的临床开发，并加强其核心技术平台的优化升级。市场分析认为，多家专业投资机构的共同参与，显示出资本市场对Opus Genetics Inc技术实力与发展前景的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194250843","title":"Opus Genetics Inc预计2025年末模拟现金余额7000万美元，将支撑运营至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1194250843","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194250843?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 20:31","pubTimestamp":1770985904,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc近日公布财务预测，预计到2025年末公司模拟现金余额将达到7000万美元。这一资金规模预计足以支持其核心研发与商业运营持续进行至2028年上半年，为基因治疗管线的长期发展提供稳定财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610672826","title":"Opus Genetics, Inc.盘中异动 下午盘股价大涨5.03%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610672826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610672826?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 04:11","pubTimestamp":1770754308,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日04时11分，Opus Genetics, Inc.股票出现异动，股价大幅拉升5.03%。Opus Genetics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211041148a494ca59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211041148a494ca59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCA","BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609231598","title":"Opus Genetics, Inc.盘中异动 急速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609231598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609231598?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 00:28","pubTimestamp":1770308922,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日00时28分，Opus Genetics, Inc.股票出现异动，股价快速拉升5.21%。Opus Genetics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020600284297a512a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020600284297a512a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRD","BK4007","BK4139","LCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609305774","title":"Opus Genetics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609305774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609305774?lang=zh_cn&edition=fundamental","pubTime":"2026-02-04 23:55","pubTimestamp":1770220528,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日23时55分，Opus Genetics, Inc.股票出现异动，股价急速下挫5.00%。Opus Genetics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204235529953fd83a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204235529953fd83a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCA","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603633716","title":"Opus Genetics, Inc.盘中异动 临近收盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603633716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603633716?lang=zh_cn&edition=fundamental","pubTime":"2026-01-13 04:31","pubTimestamp":1768249879,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日04时31分，Opus Genetics, Inc.股票出现波动，股价快速上涨5.18%。Opus Genetics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113043119953c7534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113043119953c7534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IRD","BK4139","LCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119412428","title":"Opus Genetics获得独立数据监测委员会对Best病相1/2期临床试验的积极建议","url":"https://stock-news.laohu8.com/highlight/detail?id=1119412428","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119412428?lang=zh_cn&edition=fundamental","pubTime":"2025-12-09 20:06","pubTimestamp":1765282015,"startTime":"0","endTime":"0","summary":"Opus Genetics获得独立数据监测委员会对Best病相1/2期临床试验的积极建议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586507479","title":"BUZZ--美国股票走势-Coinbase、百思买、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2586507479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586507479?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 22:16","pubTimestamp":1764080173,"startTime":"0","endTime":"0","summary":"nL6N3X10P9 ** Zeta Global Holdings Corp ZETA.N：BUZZ - 在上调季度和年度预测后上涨   nL4N3X10Q2 ** Vistra Corp VST.N：BUZZ--KeyBanc给予Vistra \"增持 \"评级。nL6N3X10S3 ** PTC Therapeutics PTCT.O：BUZZ - 该公司将加入标准普尔小型股指数，有望再创新高   nL6N3X10RH ** Firefly Aerospace Inc FLY.O：BUZZ - 因推迟上市，摩根大通下调Firefly Aerospace的PT值   nL6N3X10SL ** Lixte Biotechnology Holdings Inc LIXT.O：BUZZ - 收购英国公司，进军质子治疗癌症领域，股价上涨   nL4N3X10WN ** Keysight Technologies Inc KEYS.N：BUZZ - 因乐观的第一季度预测而跳涨；券商上调了预测价值   nL4N3X10TP (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4T3X10Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCB","PTCT","HBBD.SI","ANF","LU0708995401.HKD","UPWK","SYM","ADI","AU","BBY","CDE","DD","FLY","LU0994945656.USD","LU1301847155.USD","ZETA","LU2237443978.SGD","TITN","ALBmain","LU0496367417.USD","LU2360107325.USD","LIXT","APD","BK1610","VST","LU0943347566.SGD","ZM","KEYS","FLNC","IRD","FIBK","HL","LU2491049909.HKD","ESPR","EXOD","SPOT","COIN","IE00BFMHRM44.USD","LU0689472784.USD","89988","ATAT","LU0531971595.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2586479501","title":"BUZZ--美国股票走势-Coinbase、百思买、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2586479501","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586479501?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 22:16","pubTimestamp":1764080173,"startTime":"0","endTime":"0","summary":"nL6N3X10P9 ** Zeta Global Holdings Corp ZETA.N：BUZZ - 在上调季度和年度预测后上涨   nL4N3X10Q2 ** Vistra Corp VST.N：BUZZ--KeyBanc给予Vistra \"增持 \"评级。nL6N3X10S3 ** PTC Therapeutics PTCT.O：BUZZ - 该公司将加入标准普尔小型股指数，有望再创新高   nL6N3X10RH ** Firefly Aerospace Inc FLY.O：BUZZ - 因推迟上市，摩根大通下调Firefly Aerospace的PT值   nL6N3X10SL ** Lixte Biotechnology Holdings Inc LIXT.O：BUZZ - 收购英国公司，进军质子治疗癌症领域，股价上涨   nL4N3X10WN ** Keysight Technologies Inc KEYS.N：BUZZ - 因乐观的第一季度预测而跳涨；券商上调了预测价值   nL4N3X10TP (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4S3X10Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBY","CDE","ZM","89988","HL","LU0128525929.USD","SG9999001093.SGD","COIN","FIBK","SG9999015945.SGD","LIXT","ATAT","AU","KEYS","PTCT","ZETA","BK4101","ANF","LU0289960550.SGD","ESPR","LU0070302665.USD","LU0700851271.USD","LU0348783662.USD","UPWK","LU1211504680.USD","ALBmain","TITN","FLY","ABCB","VST","LU0543330483.HKD","LU1003077747.HKD","SPOT","SYM","IE00B543WZ88.USD","FLNC","DD","APD","HBBD.SI","IRD","EXOD","ADI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2586420356","title":"BUZZ-派博桑德勒给予 Opus Genetics \"增持 \"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2586420356","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586420356?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 20:03","pubTimestamp":1764072216,"startTime":"0","endTime":"0","summary":"BUZZ-派博桑德勒给予 Opus Genetics \"增持 \"评级11月25日 - ** Piper Sandler启动了对Opus Genetics IRD.O的覆盖，给予 \"增持 \"评级；将目标价定为7美元，与该股上次收盘价相比有约250%的上涨空间** 处于临床阶段的生物制药公司股价盘前上涨 4.5% 至 2.09 美元 ** IRD的主导项目OPGx-LCA5在一种超罕见眼病(LCA5的早期临床数据强劲，券商因此看好IRD。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4S3X10QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159635757","title":"Opus Genetics开展Opgx-Best1期1/2基因治疗临床试验，首位参与者已完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1159635757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159635757?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 20:01","pubTimestamp":1763035272,"startTime":"0","endTime":"0","summary":"Opus Genetics开展Opgx-Best1期1/2基因治疗临床试验，首位参与者已完成给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582341941","title":"Opus Genetics, Inc.盘中异动 早盘股价大跌5.08%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582341941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582341941?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 23:33","pubTimestamp":1762875222,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时33分，Opus Genetics, Inc.股票出现异动，股价急速下挫5.08%。Opus Genetics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233342a6f254df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233342a6f254df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LCA","IRD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}